These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6844614)

  • 1. Work in progress: potential oral and intravenous paramagnetic NMR contrast agents.
    Runge VM; Stewart RG; Clanton JA; Jones MM; Lukehart CM; Partain CL; James AE
    Radiology; 1983 Jun; 147(3):789-91. PubMed ID: 6844614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paramagnetic NMR contrast agents. Development and evaluation.
    Runge VM; Clanton JA; Foster MA; Smith FW; Lukehart CM; Jones MM; Partain CL; James AE
    Invest Radiol; 1984; 19(5):408-15. PubMed ID: 6439672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paramagnetic agents for contrast-enhanced NMR imaging: a review.
    Runge VM; Clanton JA; Lukehart CM; Partain CL; James AE
    AJR Am J Roentgenol; 1983 Dec; 141(6):1209-15. PubMed ID: 6606318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of paramagnetic ions bound to human serum albumin on water 1HNMR relaxation times.
    Marzola P; Cannistraro S
    Physiol Chem Phys Med NMR; 1986; 18(4):263-73. PubMed ID: 3615639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paramagnetic macrocyclic complexes as contrast agents for MR imaging: proton nuclear relaxation rate enhancement in aqueous solution and in rat tissues.
    Jackels SC; Kroos BR; Hinson WH; Karstaedt N; Moran PR
    Radiology; 1986 May; 159(2):525-30. PubMed ID: 3961187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Manganese protoporphyrin IX. A potential intravenous paramagnetic NMR contrast agent: preliminary communication.
    Jackson LS; Nelson JA; Case TA; Burnham BF
    Invest Radiol; 1985; 20(2):226-9. PubMed ID: 3988477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Particulate oral NMR contrast agents.
    Runge VM; Foster MA; Clanton JA; Smith FW; Lukehart CM; Hutchison JM; Mallard JR; Partain CL; James AE
    Int J Nucl Med Biol; 1985; 12(1):37-42. PubMed ID: 4008165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency dependence of MR relaxation times. I. Paramagnetic ions.
    Vymazal J; Bulte JW; Frank JA; Di Chiro G; Brooks RA
    J Magn Reson Imaging; 1993; 3(4):637-40. PubMed ID: 8347957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solid state 31phosphorus nuclear magnetic resonance of iron-, manganese-, and copper-containing synthetic hydroxyapatites.
    Sutter B; Taylor RE; Hossner LR; Ming DW
    Soil Sci Soc Am J; 2002; 66(2):455-63. PubMed ID: 12088032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demetalation of Fe, Mn, and Cu chelates and complexes: application to the NMR analysis of micronutrient fertilizers.
    López-Rayo S; Lucena JJ; Laghi L; Cremonini MA
    J Agric Food Chem; 2011 Dec; 59(24):13110-6. PubMed ID: 22077518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of pH on the nuclear magnetic resonance relaxivity of encapsulated solid paramagnetic substances.
    Braybrook JH; Hall LD
    Drug Des Deliv; 1989 Mar; 4(2):93-5. PubMed ID: 2765110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain nuclear magnetic resonance imaging enhanced by a paramagnetic nitroxide contrast agent: preliminary report.
    Brasch RC; Nitecki DE; Brant-Zawadzki M; Enzmann DR; Wesbey GE; Tozer TN; Tuck LD; Cann CE; Fike JR; Sheldon P
    AJR Am J Roentgenol; 1983 Nov; 141(5):1019-23. PubMed ID: 6605041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic field dependence of solvent proton relaxation induced by Gd3+ and Mn2+ complexes.
    Koenig SH; Baglin C; Brown RD; Brewer CF
    Magn Reson Med; 1984 Dec; 1(4):496-501. PubMed ID: 6443784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered transition metal homeostasis in mice following manganese injections for manganese-enhanced magnetic resonance imaging.
    Moldovan N; Al-Ebraheem A; Miksys NA; Farquharson MJ; Bock NA
    Biometals; 2013 Feb; 26(1):179-87. PubMed ID: 23334711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro evaluation of alternative oral contrast agents for MRI of the gastrointestinal tract.
    Babos M; Schwarcz A; Randhawa MS; Marton B; Kardos L; Palkó A
    Eur J Radiol; 2008 Jan; 65(1):133-9. PubMed ID: 17485189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast enhancement of magnetic resonance images by chromium EDTA: an experimental study.
    Runge VM; Foster MA; Clanton JA; Jones MM; Lukehart CM; Hutchison JM; Mallard JR; Smith FW; Partain CL; James AE
    Radiology; 1984 Jul; 152(1):123-6. PubMed ID: 6427845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new manganese-based oral contrast agent (CMC-001) for liver MRI: pharmacological and pharmaceutical aspects.
    Jørgensen JT; Rief M; Brismar TB; Wagner M; Albiin N
    Acta Radiol; 2012 Sep; 53(7):707-13. PubMed ID: 22821959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent.
    Weinmann HJ; Brasch RC; Press WR; Wesbey GE
    AJR Am J Roentgenol; 1984 Mar; 142(3):619-24. PubMed ID: 6607655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gd3+-TPPS: a potential paramagnetic contrast agent in NMR imaging.
    Marzola P; Cannistraro S
    Physiol Chem Phys Med NMR; 1987; 19(4):279-82. PubMed ID: 3449867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Work in progress: methods of contrast enhancement for NMR imaging and potential applications. A subject review.
    Brasch RC
    Radiology; 1983 Jun; 147(3):781-8. PubMed ID: 6342034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.